Two-Line Record Browser · ViralZone Data · 123 Human Viral Pathogens
A browsable reference of human viral pathogens — host & reservoir, epidemiology, transmission, tropism, pathology, and links to vaccines, antivirals, genome and proteome resources. Each virus spans two compact lines; click Pathology & sequence to expand the clinical and resource fields. See human viruses by Baltimore classification →
| Virus | Genus, Family | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence | Geography | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tropism: organ [cell type] | Pathology (fatality rate) | Vaccine | Antivirals | Genome assembly | Genome (non-segmented) | Proteome | Cell culture | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Polyomavirus, Polyomaviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence | Geography Worldwide | Transmission Urine or blood | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Seadornavirus, Reoviridae | Host / Reservoir [occasional host] Cattle, Pig, Culex mosquito, [Human] | Epidemiology | Incidence / prevalence Incidence <1/year | Geography Asia (Vietnam, Indonesia, and China) | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown, [Nervous system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Marsupials, Aedes mosquito , [Human] | Epidemiology | Incidence / prevalence | Geography Australia | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown , Joint tissue | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Orthobunyavirus, Bunyaviridae, Bunyamwera serogroup | Host / Reservoir [occasional host] Primates, Aedes mosquito, [Human] | Epidemiology | Incidence / prevalence Unknown (low, underreported) | Geography | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture Not available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Batai virus (BATV) +Chittoor virus (CHITV) | Genus, Family Orthobunyavirus, Bunyaviridae, Bunyamwera serogroup | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence Unknown (very low) | Geography | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Orthobunyavirus, Bunyaviridae, Bunyamwera serogroup | Host / Reservoir [occasional host] Vertebrate, Aedes mosquito, [Human] | Epidemiology | Incidence / prevalence Unknown (very low) | Geography | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture Not available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus La Crosse encephalitis virus (LACV), (Bunyavirus La Crosse) +Jamestown Canyon virus | Genus, Family Orthobunyavirus, Bunyaviridae, California serogroup | Host / Reservoir [occasional host] Mammals, Culex mosquito , [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Snowshoe hare virus (SSHV), (Bunyavirus snowshoe hare) | Genus, Family Orthobunyavirus, Bunyaviridae, California serogroup | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Macacine alphaherpesvirus 1; (McHV-1) , | Genus, Family Simplexvirus, Herpesviridae | Host / Reservoir [occasional host] Macaque, [Human] | Epidemiology | Incidence / prevalence <1/year | Geography Asia, Indonesia | Transmission Zoonosis, animal bite | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Mucous epithelium Secondary: Nervous system | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Vesiculovirus, Rhabdoviridae | Host / Reservoir [occasional host] Sandflies, [Human] | Epidemiology | Incidence / prevalence (2009) 52 [15] (2010) 50 [16] | Geography Asia (India, Bhutan, Nepal, Sri Lanka), Africa (Nigeria, Senegal) | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Vertebrate, Aedes mosquito, [Human] | Epidemiology | Incidence / prevalence (2023) 460,000 [360] | Geography Africa, Asia | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Skin | Pathology (fatality rate)
| Vaccine Chikungunya Vaccine, Recombinant (VIMKUNYA)FDAEMA Chikungunya Vaccine, Live, Attenuated (IXCHIQ)EMA US licence suspended Aug 2025 over safety signals in adults 65+; still authorised in EU (restricted use). | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Human Cosavirus A (HCoSV-A) | Genus, Family Cosavirus, Picornaviridae | Host / Reservoir [occasional host] Human | Epidemiology Unknown | Incidence / prevalence — | Geography — | Transmission Fecal-oral (probable) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Orthopoxvirus, Poxviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence | Geography | Transmission Zoonosis, contact | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Enterovirus, Picornaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence | Geography Worldwide; (Enterovirus 71): more common in Asia-pacific | Transmission Fecal-oral; Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Tonsil *-First viremia* Secondary: Skin ![]() | Pathology (fatality rate)
| Vaccine | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Coxsackievirus B (CVB) (=Enterovirus B) ECDC | Genus, Family Enterovirus, Picornaviridae | Host / Reservoir [occasional host] Human | Epidemiology Seasonal (Summer), Endemic | Incidence / prevalence | Geography Worldwide | Transmission Fecal-oral; Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Gastrointestinal tract *-First viremia* Secondary: Pancreas Persistence: (Latency) Gastrointestinal tract ![]() | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family | Host / Reservoir [occasional host] Tick, [Human, Vertebrates] ![]() | Epidemiology | Incidence / prevalence Incidence: 10-500/year | Geography Africa, Europe (Balkans, Greece), Asia (Middle East and west Asia) | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Immune system *-Viremia* Secondary: Endothelial cell ![]() | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Flavivirus, Flaviviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence (2023) 6 million [6000] | Geography North America and South America, Central Africa, Australia, Oceania, Asia, Europe (Italy, France, Spain) | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Skin *Viremia* Secondary: Immune system ![]() | Pathology (fatality rate)
| Vaccine Dengue Tetravalent Vaccine, Live (DENGVAXIA)FDA source Withdrawn from the EU market Oct 2025 (commercial reasons, not safety). Dengue Tetravalent Vaccine, Live, Attenuated (QDENGA)EMA | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Thogotovirus, Orthomyxoviridae | Host / Reservoir [occasional host] Tick, Vertebrate [Human, Mosquitoes] | Epidemiology | Incidence / prevalence | Geography (DHOV, THOV) Africa, Asia, Europe, (BKNV) Europe, (BRBV) North America | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) Unknown | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Dugbe virus (DUGV) | Genus, Family | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence Incidence: very low <1 year, underreported | Geography Africa | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Beiji nairovirus (BJNV) | Genus, Family Norwavirus, Nairoviridae | Host / Reservoir [occasional host] Vertebrate, Tick, [Human, sheep, cattle] | Epidemiology Sporadic, Seasonal (spring-summer) | Incidence / prevalence Incidence: very low <40 year, underreported | Geography Asia (China, Mongolia) | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown (Liver, heart and kidney?) | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals Ribavirin (off-label use) | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Birds, Aedes mosquito, Culex mosquito, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Ebolavirus Zaïre (EBOV, ZEBOV) + ebolavirus Bombali (BOMV) + ebolavirus Bundibugyo (BDBV, BEBOV) + ebolavirus Reston (RESTV, REBOV) + ebolavirus Forêt de Taï (TAFV, CIEBOV) + ebolavirus Soudan (SUDV, SEBOV) | Genus, Family Ebolavirus, Filoviridae | Host / Reservoir [occasional host] Bat, [Monkeys, Human] | Epidemiology | Incidence / prevalence — | Geography Africa ( Central Africa (EBOV), West Africa (EBOV,BOMV), Sudan (SUDV) , Côte d'Ivoire (TAFV), Uganda (BDBV, SUDV) ), Asia( Philippines (RESTV)) | Transmission Zoonosis, contact | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Immune system *-Viremia* Secondary: Liver | Pathology (fatality rate)
| Vaccine | Antivirals (EBOV) Monoclonal antibodies, Remdesivir ![]() | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Enterovirus, Picornaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography Worldwide | Transmission Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Larynx epithelium Secondary: Nervous system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Encephalomyocarditis virus (EMCV) | Genus, Family Cardiovirus, Picornaviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Lymphocryptovirus, Herpesviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Contact, saliva | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Buccal epithelium *-Viremia* Secondary: Immune system Persistence: (Latency) Immune system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Blood, occasionally sexual | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Henipavirus, paramyxoviridae | Host / Reservoir [occasional host] Bat, [Human, Horse] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Hepatovirus, picornaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Liver | Pathology (fatality rate)
| Vaccine Hepatitis A Vaccine, Inactivated (Havrix)FDAEMA source Hepatitis A Vaccine, Inactivated (VAQTA)FDA Hepatitis A Vaccine (inactivated) (Avaxim)EMA source Hepatitis A Inactivated and Hepatitis B (Recombinant) Vaccine (Twinrix)FDAEMA source | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Orthohepadnavirus, Hepadnaviridae | Host / Reservoir [occasional host] Human, Non-human primates | Epidemiology | Incidence / prevalence — | Geography — | Transmission Sexual contact, Contact: blood, Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Transported: in blood by [Macrophage Primary: Liver Persistence: (Chronic) Liver | Pathology (fatality rate) | Vaccine Hepatitis B Vaccine (Recombinant) (Recombivax HB)FDA Hepatitis B Vaccine (Recombinant) (Engerix-B)FDAEMA source Hepatitis B Vaccine (rDNA) (HBVAXPRO)EMA source EU equivalent formulation of Recombivax HB. Hepatitis B Vaccine (Recombinant) (PREHEVBRIO)FDAEMA source Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B)FDA Hepatitis B Vaccine, Adjuvanted (for renal impairment) (Fendrix)EMA source | Antivirals (Entecavir, Tenofovir, Adefovir, Lamivudine, Telbivudine) | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Hepacivirus, Flaviviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Sexual Contact; Contact: Blood; Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals PEG interferon, Ribavirin, Direct-acting-Antivirals: RNA pol inhibitors, NS5A inhibitors, NS3/4A protease inhibitor | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Hepevirus, Unassigned | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate) | Vaccine Hepatitis E Vaccine, Recombinant (Hecolin)CHINA source Xiamen Innovax; world's first licensed Hepatitis E vaccine, approved by China NMPA in 2011 (not FDA/EMA-approved). | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Deltavirus, Unassigned | Host / Reservoir [occasional host] Human | Epidemiology Endemic, satellite virus of HBV | Incidence / prevalence — | Geography — | Transmission Sexual contact, blood | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine Indirect protection: HDV requires HBV co-infection, so Hepatitis B vaccination prevents HDV. Hepatitis B Vaccine (Recombinant) (Recombivax HB)FDA Hepatitis B Vaccine (Recombinant) (Engerix-B)FDAEMA Hepatitis B Vaccine (rDNA) (HBVAXPRO)EMA source | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Mastadenovirus, Adenoviridae | Host / Reservoir [occasional host] Human | Epidemiology Seasonal (Winter), Endemic | Incidence / prevalence — | Geography Worldwide | Transmission Respiratory aerosols, fomites, fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] (subgroup B, C, E): Pharynx (Subgroup B): Urethra (Subgroups A, F, G): Intestinal epithelium (Subgroups D): Cornea Persistence: (Latency) (Serogroup C): Adenoid and tonsil | Pathology (fatality rate)
| Vaccine Adenovirus Type 4 and Type 7 Vaccine, Live, OralFDA US military recruits only; no EMA- or China-approved adenovirus vaccine identified. | Antivirals Cidofovir | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Mamastrovirus, Astroviridae | Host / Reservoir [occasional host] Human | Epidemiology Seasonal (Winter), Endemic | Incidence / prevalence — | Geography — | Transmission Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Human coronavirus (HCoV) | Genus, Family | Host / Reservoir [occasional host] Human, Bat (NL63) | Epidemiology Seasonal (Winter), Endemic | Incidence / prevalence — | Geography — | Transmission Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Cytomegalovirus, Herpesviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography Worldwide | Transmission Contact: Saliva, Urine, Breastmilk; Sexual contact: Genital secretions; Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Respiratory tract Epithelium [Epithelial cells], Immune system *-First viremia* Secondary: lung, hepatocytes, tubular and glomerular kidney cells, splenic red pulp cells, pancreatic acinar cells, Endothelium ] Persistence: (Latency) Immune system ![]() ![]() | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals (Acyclovir, Foscarnet) | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Human enterovirus D68 (EV-D68), 70 (EV-70) | Genus, Family Enterovirus, Picornaviridae | Host / Reservoir [occasional host] Human | Epidemiology Seasonal (Spring/Summer), Endemic | Incidence / prevalence — | Geography — | Transmission Respiratory aerosols | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary:Pharynx Secondary:Nervous system | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Simplexvirus, Herpesviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Sexual contact, saliva | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Mouth mucosa Secondary: Lung *-Viremia* Secondary: Nervous system Persistence: (latency) Nervous system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals (Acyclovir, Foscarnet) | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Simplexvirus, Herpesviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Sexual contact; Contact: saliva; Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Genital tissue *-Viremia* Secondary: Nervous system Persistence: (latency) Nervous system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals (Acyclovir, Foscarnet) | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Roseolovirus, Herpesviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Contact: Saliva | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Immune system *-Viremia* Secondary: Salivary glands Persistence: (Latency) Immune system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Roseolovirus, Herpesviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory, contact | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Immune system *-Viremia* Secondary: Salivary glands Persistence: (Latency) Immune system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Human herpesvirus 8 (HHV-8), Kaposi's sarcoma-associated herpesvirus (KSHV) | Genus, Family Rhadinovirus, Herpesviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Sexual contact, saliva, mosquito bite | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Immune system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Lentivirus, Retroviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Sexual contact; Contact: Blood; Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Immune system Persistence: (Latency) Immune system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Metapneumovirus, Pneumoviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Upper respiratory tract | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Contact, Sexual contact, Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Cutaneous HPV (Alpha, Beta, Gamma Mu and Nu papillomavirus: Skin Persistence: (Latency) basal or germ cells of the epidermis | Pathology (fatality rate)
| Vaccine Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant (Gardasil)FDAEMA Human Papillomavirus 9-valent Vaccine, Recombinant (Gardasil 9)FDAEMA Human Papillomavirus Bivalent (Types 16, 18) Vaccine, Recombinant (Cervarix)FDAEMA Human Papillomavirus Bivalent Vaccine, Recombinant (Cecolin)CHINA source Domestic Chinese HPV vaccine (Xiamen Innovax), WHO-prequalified. | Antivirals None | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Human parainfluenzavirus 1 (HPIV-1) and 3 (HPIV-3) (Human Respirovirus 1 and 3) | Genus, Family Respirovirus, Paramyxoviridae | Host / Reservoir [occasional host] Human | Epidemiology Seasonal (HPIV-1 Fall, HPIV-3 Summer), Endemic | Incidence / prevalence — | Geography — | Transmission Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Upper respiratory tract | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Human parainfluenzavirus 2 (HPIV-2) and 4 (HPIV-4) (Human Rubulavirus 2 and 4) | Genus, Family Orthorubulavirus, Paramyxoviridae | Host / Reservoir [occasional host] Human | Epidemiology Respiratory | Incidence / prevalence — | Geography — | Transmission Seasonal (Fall-Winter), Endemic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] trachea epithelial cells | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Erythrovirus, Parvoviridae | Host / Reservoir [occasional host] Human | Epidemiology Partly seasonal (Spring), Endemic | Incidence / prevalence — | Geography — | Transmission Respiratory; Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Bone marrow Persistence: (Latency) Spleen | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Bocaparvovirus, Parvoviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory, fecal–oral? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Orthopneumovirus, Pneumoviridae | Host / Reservoir [occasional host] Human | Epidemiology Seasonal (Fall-Winter), Endemic | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: upper respiratory epithelium Secondary: lower respiratory epithelium, Immune system | Pathology (fatality rate)
| Vaccine Respiratory Syncytial Virus Vaccine (MRESVIA)FDA Respiratory Syncytial Virus Vaccine (ABRYSVO)FDAEMA Respiratory Syncytial Virus Vaccine, Adjuvanted (AREXVY)FDAEMA | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family | Host / Reservoir [occasional host] Human | Epidemiology Seasonal (early autumn, late spring in temperate zones), Endemic | Incidence / prevalence — | Geography Worldwide | Transmission Respiratory aerosols, Contact: Fomites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals None | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Betacoronavirus, Coronaviridae | Host / Reservoir [occasional host] Bat, [Human, Palm civet] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Zoonosis, Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Lung ![]() | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Simiispumavirus, Retroviridae | Host / Reservoir [occasional host] Primate, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Zoonosis, Contact, saliva | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Deltaretrovirus, Retroviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography Asia (Japan, Caribbean), Africa | Transmission Sexual contact; Contact: Blood; Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals Prosultiamine, Azacitidine, Tenofovir | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Torovirus, Coronaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly NA | Genome (non-segmented) NA | Proteome NA | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Influenzavirus A, Orthomyxoviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory aerosols | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Upper respiratory tract Secondary: Lower respiratory tract *Viremia* (rare) Tertiary: myotubes? ![]() | Pathology (fatality rate)
| Vaccine Influenza Virus Vaccine (Quadrivalent, standard-dose, egg-based) (Fluarix Quadrivalent)FDA Influenza vaccine (split virion, inactivated, quadrivalent) (Fluarix Tetra)EMA source Influenza Virus Vaccine (Quadrivalent, standard-dose, egg-based) (FLULAVAL QUADRIVALENT)FDA Influenza Vaccine (Quadrivalent, standard-dose, egg-based) (Afluria Quadrivalent)FDA Influenza Virus Vaccine (Quadrivalent, standard-dose, egg-based) (Fluzone Quadrivalent)FDA For adults under 65; adults 65+ receive the high-dose formulation instead. Influenza Virus Vaccine (Quadrivalent, high-dose, egg-based) (Fluzone High-Dose Quadrivalent)FDA For adults aged 65 and older. Influenza vaccine (split virion, inactivated, high-dose, quadrivalent) (Efluelda)EMA source EU high-dose vaccine for adults 60+ (Sanofi); same active substance family as Fluzone High-Dose. Influenza vaccine, quadrivalent (split virion, inactivated) (Vaxigrip Tetra)EMA source Nationally authorised across EU member states (Sanofi); active for the 2025-2026 season. Influenza vaccine, quadrivalent (surface antigen, inactivated) (Influvac Tetra)EMA source Nationally authorised across EU member states (Viatris); active for the 2025-2026 season. Influenza Vaccine, Adjuvanted (Quadrivalent) (Fluad Quadrivalent)FDA Adjuvanted formulation for adults aged 65 and older. Influenza vaccine (surface antigen, inactivated, adjuvanted, quadrivalent) (Fluad Tetra)EMA EU marketing authorisation withdrawn Feb 2026 (commercial reasons, manufacturer Seqirus). Influenza Vaccine (Quadrivalent, cell-based, non-egg) (Flucelvax Quadrivalent)FDA Influenza vaccine (surface antigen, inactivated, cell-based, quadrivalent) (Flucelvax Tetra)EMA EU marketing authorisation withdrawn Feb 2026 (commercial reasons, manufacturer Seqirus). Influenza Vaccine (Quadrivalent, recombinant, protein-based, non-egg) (Flublok Quadrivalent)FDA Quadrivalent influenza vaccine (recombinant, cell culture) (Supemtek Tetra)FDAEMA Sold as Supemtek in the US (FDA) and Supemtek Tetra in the EU (EMA). Influenza Vaccine, Live, Intranasal (Quadrivalent) (FluMist Quadrivalent)FDA Live attenuated, needle-free nasal spray. Influenza vaccine (live attenuated, nasal, quadrivalent) (Fluenz Tetra)EMA EU marketing authorisation withdrawn July 2025 (commercial reasons, manufacturer AstraZeneca); same vaccine family as FluMist. Influenza Vaccine, mRNA (Quadrivalent) (MFLUSIVA)FDA First mRNA-based influenza vaccine to be licensed; no EMA-authorised mRNA flu vaccine identified yet. China: multiple domestic quadrivalent/trivalent influenza vaccines are NMPA-approved (e.g. by Hualan Biological, Sinovac, CNBG), but reliable English-language documentation of individual product names and current status was not found. | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Influenzavirus A, Orthomyxoviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence (H5N1: 45/year) (H7N2: <1/year) (H7N7: <1/year) (H7N9: 1-800/year) (H9N2: 4/year) | Geography Worldwide | Transmission Zoonosis, animal contact | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tropism: organ [cell type]
| Pathology (fatality rate)
| Vaccine Influenza A (H5N1) Monovalent Vaccine, Adjuvanted (AUDENZ)FDA Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (AREPANRIX)FDA Influenza Virus Vaccine, H5N1FDA Held in the U.S. National Stockpile for pandemic preparedness, not for routine use. Pandemic influenza vaccine (H5N1), adjuvanted (Foclivia)EMA Seqirus, egg-based; authorised for use once a pandemic is officially declared. Pandemic influenza vaccine (H5N1), split virion, adjuvanted (Adjupanrix)EMA GSK, egg-based mock-up vaccine. Zoonotic influenza vaccine (H5N1), cell-based, adjuvanted (Incellipan)EMA Seqirus; pandemic-preparedness use only. No FDA- or EMA-licensed vaccine identified for H7N2, H7N7, H7N9, or H9N2 avian influenza subtypes. | Antivirals (Oseltamivir, Zanamivir, Peramivir, Baloxavir marboxil) | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Influenzavirus B, Orthomyxoviridae | Host / Reservoir [occasional host] Human, Pig, Seal | Epidemiology Seasonal (Winter), Endemic [B/Yamagata extinct 2021] | Incidence / prevalence — | Geography — | Transmission Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine Influenza Virus Vaccine (Quadrivalent, standard-dose, egg-based) (Fluarix Quadrivalent)FDA Influenza vaccine (split virion, inactivated, quadrivalent) (Fluarix Tetra)EMA source Influenza Virus Vaccine (Quadrivalent, standard-dose, egg-based) (FLULAVAL QUADRIVALENT)FDA Influenza Vaccine (Quadrivalent, standard-dose, egg-based) (Afluria Quadrivalent)FDA Influenza Virus Vaccine (Quadrivalent, standard-dose, egg-based) (Fluzone Quadrivalent)FDA For adults under 65; adults 65+ receive the high-dose formulation instead. Influenza Virus Vaccine (Quadrivalent, high-dose, egg-based) (Fluzone High-Dose Quadrivalent)FDA For adults aged 65 and older. Influenza vaccine (split virion, inactivated, high-dose, quadrivalent) (Efluelda)EMA source EU high-dose vaccine for adults 60+ (Sanofi); same active substance family as Fluzone High-Dose. Influenza vaccine, quadrivalent (split virion, inactivated) (Vaxigrip Tetra)EMA source Nationally authorised across EU member states (Sanofi); active for the 2025-2026 season. Influenza vaccine, quadrivalent (surface antigen, inactivated) (Influvac Tetra)EMA source Nationally authorised across EU member states (Viatris); active for the 2025-2026 season. Influenza Vaccine, Adjuvanted (Quadrivalent) (Fluad Quadrivalent)FDA Adjuvanted formulation for adults aged 65 and older. Influenza vaccine (surface antigen, inactivated, adjuvanted, quadrivalent) (Fluad Tetra)EMA EU marketing authorisation withdrawn Feb 2026 (commercial reasons, manufacturer Seqirus). Influenza Vaccine (Quadrivalent, cell-based, non-egg) (Flucelvax Quadrivalent)FDA Influenza vaccine (surface antigen, inactivated, cell-based, quadrivalent) (Flucelvax Tetra)EMA EU marketing authorisation withdrawn Feb 2026 (commercial reasons, manufacturer Seqirus). Influenza Vaccine (Quadrivalent, recombinant, protein-based, non-egg) (Flublok Quadrivalent)FDA Quadrivalent influenza vaccine (recombinant, cell culture) (Supemtek Tetra)FDAEMA Sold as Supemtek in the US (FDA) and Supemtek Tetra in the EU (EMA). Influenza Vaccine, Live, Intranasal (Quadrivalent) (FluMist Quadrivalent)FDA Live attenuated, needle-free nasal spray. Influenza vaccine (live attenuated, nasal, quadrivalent) (Fluenz Tetra)EMA EU marketing authorisation withdrawn July 2025 (commercial reasons, manufacturer AstraZeneca); same vaccine family as FluMist. Influenza Vaccine, mRNA (Quadrivalent) (MFLUSIVA)FDA First mRNA-based influenza vaccine to be licensed; no EMA-authorised mRNA flu vaccine identified yet. China: multiple domestic quadrivalent/trivalent influenza vaccines are NMPA-approved (e.g. by Hualan Biological, Sinovac, CNBG), but reliable English-language documentation of individual product names and current status was not found. | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Influenzavirus C, Orthomyxoviridae | Host / Reservoir [occasional host] Human, Pig | Epidemiology Seasonal (Winter), Endemic | Incidence / prevalence — | Geography — | Transmission Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Isfahan virus (ISFV) | Genus, Family Vesiculovirus, Rhabdoviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Polyomavirus, Polyomaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence Worldwide | Geography | Transmission Respiratory, Contact: Fecal-oral or urine | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Tonsil *-Viremia* Secondary: Kidney Reactivation (Immunodeficiency): Nervous system Persistence: (Latency) Kidney ![]() | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals None | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Orthoflavivirus, Flaviviridae | Host / Reservoir [occasional host] Bird, Culex mosquito, Pig, [Human, horses] | Epidemiology | Incidence / prevalence | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine Japanese Encephalitis Virus Vaccine, Inactivated, Adsorbed (Ixiaro)FDAEMA Live Attenuated SA14-14-2 Japanese Encephalitis Vaccine (CD-JEVAX)CHINA source Chengdu Institute of Biological Products; WHO-prequalified, used across Asia. | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Arenavirus, Arenaviridae | Host / Reservoir [occasional host] Rodent, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Zoonosis, fomite | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Polyomavirus, Polyomaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Marburgvirus, Filoviridae | Host / Reservoir [occasional host] Bat, [Human, Monkeys] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Zoonosis, fomite | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Immune system Secondary: Endothelial cell | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals Monoclonal antibodies, Remdesivir ![]() | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Tick-borne encephalitis virus (TBEV) (+Powassan virus (POWV), Kyasanur Forest disease virus (KFDV), Alkhurma virus (ALKV), and Omsk hemorrhagic fever virus (OHFV)) | Genus, Family Flavivirus, Flaviviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Skin dendritic (or Langerhans cell Secondary: migratory DCs and Macrophage | Pathology (fatality rate)
| Vaccine Tick-Borne Encephalitis Vaccine (TICOVAC)FDA Tick-Borne Encephalitis Vaccine (FSME-IMMUN)EMA source Tick-Borne Encephalitis Vaccine (Encepur)EMA source | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Arenavirus, Arenaviridae | Host / Reservoir [occasional host] Rodent, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Zoonosis, urine, fomites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals Ribavirin | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Arenavirus, Arenaviridae | Host / Reservoir [occasional host] Rodent, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Zoonosis, fomite | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Machupo virus (MACV) | Genus, Family Arenavirus, Arenaviridae | Host / Reservoir [occasional host] Rodent, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Zoonosis, fomite | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Primate, Aedes mosquito, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus MERS coronavirus (MERS-CoV) | Genus, Family Betacoronavirus, Coronaviridae | Host / Reservoir [occasional host] Tomb bat, [Human, Camel] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Morbilivirus, Paramyxoviridae | Host / Reservoir [occasional host] Human | Epidemiology Seasonal (Winter)(temperate countries)Endemic | Incidence / prevalence Incidence: 9 million/year (2022) | Geography — | Transmission Respiratory aerosols | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Immune system *-Viremia* Secondary: Respiratory tract Persistence: (Latency) Brain ![]() | Pathology (fatality rate)
| Vaccine Measles, Mumps and Rubella Vaccine, Live (PRIORIX)FDAEMA Measles, Mumps, and Rubella Virus Vaccine, Live (M-M-R II)FDA Measles, Mumps and Rubella Vaccine, Live (M-M-RVAXPRO)EMA source EU-marketed equivalent of M-M-R II. Measles, Mumps, Rubella and Varicella Virus Vaccine Live (ProQuad)FDAEMA | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Polyomavirus, Polyomaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Mokola virus (MOKV) +Lagos bat virus (LBV) + Shimoni bat virus (SHIBV) | Genus, Family Lyssavirus, Rhabdoviridae | Host / Reservoir [occasional host] Unknown, Rodent, [Human, Cat, Dog] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Peripheral nervous system Secondary: Central nervous system | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Molluscipoxvirus, Poxviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Contact | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family | Host / Reservoir [occasional host] Unknown, Rodent, Human ![]() | Epidemiology | Incidence / prevalence (Clade I(2024): 16,000) (Clade IIb(2022): 92,167) | Geography | Transmission Zoonosis, contact | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Immune system Secondary: Skin, ![]() | Pathology (fatality rate)
| Vaccine Smallpox and Monkeypox Vaccine, Live, Non-Replicating (JYNNEOS)FDA Smallpox and Monkeypox Vaccine, Live, Non-Replicating (MVA-BN) (IMVANEX)EMA Same Bavarian Nordic MVA-BN vaccine as JYNNEOS, marketed under a different name in the EU. Smallpox and Mpox (Vaccinia) Vaccine, Live (ACAM2000)FDA | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Rubulavirus, Paramyxoviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory, saliva | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine Measles, Mumps and Rubella Vaccine, Live (PRIORIX)FDAEMA Measles, Mumps, and Rubella Virus Vaccine, Live (M-M-R II)FDA Measles, Mumps and Rubella Vaccine, Live (M-M-RVAXPRO)EMA source EU-marketed equivalent of M-M-R II. Measles, Mumps, Rubella and Varicella Virus Vaccine Live (ProQuad)FDAEMA | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family | Host / Reservoir [occasional host] Bird, Culex mosquito, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Henipavirus, Paramyxoviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Respiratory tract | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Henipavirus, Paramyxoviridae | Host / Reservoir [occasional host] Shrew, [Human] | Epidemiology — | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] — | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Norovirus (NoV) (+Norwalk virus, +Desert shield virus, +Hawaii virus, +Lordsdale virus, +Mexico virus, +Snow Mountain virus, +Southampton virus) | Genus, Family Norovirus, Caliciviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Vertebrate, Anopheles Mosquito [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Parapoxvirus, Poxviridae | Host / Reservoir [occasional host] Mammal, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Zoonosis, contact | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Enterovirus, Picornaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Pharynx Secondary: Nervous system | Pathology (fatality rate)
| Vaccine Poliovirus Vaccine Inactivated (Human Diploid Cell) (Poliovax)FDA Poliovirus Vaccine Inactivated (Monkey Kidney Cell) (IPOL)FDA Poliomyelitis Vaccine, Inactivated (Imovax Polio)EMA source not verified | Antivirals None | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Phlebovirus, Phenuiviridae | Host / Reservoir [occasional host] Vertebrate, Sandflies, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Dar es Salaam virus (DeSV) | Genus, Family Tanzavirus, Phenuiviridae | Host / Reservoir [occasional host] Vertebrate?, Insect?, [Human] | Epidemiology | Incidence / prevalence Incidence <1/year, underreported | Geography Africa (Tanzania) | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Hantaan virus (HTNV) (+ Seoul virus, Amur virus) | Genus, Family | Host / Reservoir [occasional host] Rodent, [Human] | Epidemiology | Incidence / prevalence Incidence>10,000 case/year | Geography China, Korea, Japan | Transmission Zoonosis, urine, saliva | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Endothelium ![]() | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Puumala virus (PUUV) (+Saaremaa virus, Dobrava virus) | Genus, Family | Host / Reservoir [occasional host] Bank vole, [Human] | Epidemiology | Incidence / prevalence Incidence>1,000 case/year | Geography Central, North and East Europe | Transmission Zoonosis, urine, saliva | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Endothelium ![]() | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Andes virus (+Sin Nombre virus (SNV), Black Creek Canal virus, New York orthohantavirus, Monongahela virus) | Genus, Family | Host / Reservoir [occasional host] Rodent, [Human] | Epidemiology | Incidence / prevalence Incidence: (Andes >100/year) (Sin Nombre virus >25/year) | Geography (Andes: South America) (Sin Nombre virus: Central and North America) | Transmission Zoonosis, urine, saliva (Andes: respiratory) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Endothelium ![]() | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly NA | Genome (non-segmented) NA | Proteome NA | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Rabies virus (RABV) +Aravan virus (ARAV) +Duvenhage virus (DUVV) +Australian bat lyssavirus (ABLV) +European bat lyssavirus (EBLV) +Irkut virus (IRKV) +Khujand virus (KHUV) | Genus, Family Lyssavirus, Rhabdoviridae | Host / Reservoir [occasional host] Carnivorous mammal, Bat, [Human] | Epidemiology | Incidence / prevalence — | Geography Worldwide | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Peripheral nervous system Secondary: Central nervous system | Pathology (fatality rate) | Vaccine Rabies Vaccine (IMOVAX RABIES)FDA Rabies Vaccine (RabAvert)FDA Rabies Vaccine (purified chick embryo cell) (Rabipur)EMA source Same manufacturer/strain as RabAvert, marketed under a different name in the EU. Rabies Vaccine (purified Vero cell) (Verorab)EMA source not verified Rabies Vaccine, Vero cell (multiple domestic manufacturers)CHINA source not verified Rabies Vaccine AdsorbedFDA | Antivirals None | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Phlebovirus, Phenuiviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Rosavirus, Picornaviridae | Host / Reservoir [occasional host] Rodent, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Ross river virus (RRV) | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family | Host / Reservoir [occasional host] Rodents, Deer, Tick, [Human, Cattle] | Epidemiology Sporadic | Incidence / prevalence Incidence: 6/year | Geography North America (CTFV): USA, Canada, Europe (EYAV) | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals None | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Rotavirus, Reoviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Seasonal (Winter and spring in temperates area), Contact: Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine Rotavirus Vaccine, Live, Oral (ROTARIX)FDAEMA Rotavirus Vaccine, Live, Oral, Pentavalent (RotaTeq)FDAEMACHINA source Lanzhou Lamb Rotavirus Vaccine (trivalent, live, oral) (LLR)CHINA source China's original domestic rotavirus vaccine (Lanzhou Institute); newer hexavalent domestic vaccine approved 2025. | Antivirals None | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Rotavirus, Reoviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Seasonal (Winter and spring in temperates area), Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals None | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Rotavirus, Reoviridae | Host / Reservoir [occasional host] Pig, Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Rubella virus (RUBV) | Genus, Family Rubivirus, Togaviridae | Host / Reservoir [occasional host] Human | Epidemiology Seasonal (Spring), Endemic | Incidence / prevalence — | Geography Worldwide | Transmission Respiratory, Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine Measles, Mumps and Rubella Vaccine, Live (PRIORIX)FDAEMA Measles, Mumps, and Rubella Virus Vaccine, Live (M-M-R II)FDA Measles, Mumps and Rubella Vaccine, Live (M-M-RVAXPRO)EMA source EU-marketed equivalent of M-M-R II. Measles, Mumps, Rubella and Varicella Virus Vaccine Live (ProQuad)FDAEMA | Antivirals None | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Getah virus (GETV) +Sagiyama virus | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Vertebrate, Mosquito, [Human, Horse, Pig] ![]() | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Salivirus, Picornaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Fecal-oral? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Sapovirus, Caliciviridae | Host / Reservoir [occasional host] Human, Pig | Epidemiology | Incidence / prevalence — | Geography — | Transmission Fecal-oral | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Human SARS coronavirus 2 (SARS-CoV-2) | Genus, Family Betacoronavirus, Coronaviridae | Host / Reservoir [occasional host] Human, [Bat, pangolin] | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Upper respiratory tract ![]() ![]() | Pathology (fatality rate) | Vaccine COVID-19 Vaccine, mRNA (MNEXSPIKE)FDA COVID-19 Vaccine, Adjuvanted (protein subunit) (NUVAXOVID)FDAEMA COVID-19 Vaccine, mRNA (Comirnaty)FDAEMA COVID-19 Vaccine, mRNA (SPIKEVAX)FDAEMA COVID-19 Vaccine, Inactivated (CoronaVac)CHINA source Sinovac; one of China's principal domestic COVID-19 vaccines. COVID-19 Vaccine, Inactivated (BBIBP-CorV)CHINA source Sinopharm/Beijing Institute of Biological Products. | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Bird, Hedgehog, Aedes mosquito, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Birds, Culex mosquito, Culiseta mosquito, [Human, Vertebrates] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Flavivirus, Flaviviridae | Host / Reservoir [occasional host] Bird, Culex mosquito, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Haseki tick virus (HSTV) | Genus, Family unassigned genus, Flaviviridae | Host / Reservoir [occasional host] Tick, [Human] | Epidemiology | Incidence / prevalence Unknown (very low) (<5/year) | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly — | Genome (non-segmented) | Proteome — | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Torque teno virus (TTV) | Genus, Family | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary:Gastrointestinal tract *-Viremia* Secondary: Liver ![]() ![]() | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals None | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Sandfly fever Naples phlebovirus (SFNV) + Sandfly fever Sicilian virus (SFSV) + Toscana virus (TOSV) +Massilia virus (MASV) | Genus, Family Phlebovirus, Phenuiviridae | Host / Reservoir [occasional host] *Phlebotomus sandflies, [Human] | Epidemiology Seasonal (Summer), Outbreaks | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Unknown, (TOSV: Nervous system | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Uukuniemi virus (UUKV) + Zaliv Terpeniya virus (ZTV) | Genus, Family Uukuvirus, Phenuiviridae | Host / Reservoir [occasional host] Tick, Aedes mosquito , Bird, [Human] | Epidemiology — | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Dabie bandavirus Severe fever with thrombocytopenia syndrome virus (SFTSV) | Genus, Family Bandavirus, Phenuiviridae | Host / Reservoir [occasional host] Vertebrate, Tick, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) NA | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Vaccinia virus (VACV or VV) (+Horsepox virus) | Genus, Family Orthopoxvirus, Poxviridae | Host / Reservoir [occasional host] Human, mammals | Epidemiology Vaccination, Sporadic | Incidence / prevalence — | Geography — | Transmission Contact | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Skin | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Varicellovirus, Herpesviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory; Contact; Vertical transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Mouth mucosa Secondary: Immune system Persistence: (Latency) Dorsal root ganglion ![]() | Pathology (fatality rate)
| Vaccine Varicella Virus Vaccine Live (Varivax)FDAEMA Varicella Virus Vaccine Live (Varilrix)EMA source Zoster Vaccine, Live, (Oka/Merck) (Zostavax)FDA source Discontinued in the EU/UK as of 2026; largely superseded by Shingrix. Zoster Vaccine Recombinant, Adjuvanted (SHINGRIX)FDAEMA Measles, Mumps, Rubella and Varicella Virus Vaccine Live (ProQuad)FDAEMA | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Smallpox virus (Variola virus (VARV)) | Genus, Family Orthopoxvirus, Poxviridae | Host / Reservoir [occasional host] Human | Epidemiology Extinct, Eradicated (1980) | Incidence / prevalence — | Geography — | Transmission Respiratory, Contact: Fomites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Mouth mucosa *-First viremia* Secondary: Immune system *-Second viremia* Tertiary: Skin ![]() | Pathology (fatality rate) | Vaccine Smallpox and Monkeypox Vaccine, Live, Non-Replicating (JYNNEOS)FDA Smallpox and Monkeypox Vaccine, Live, Non-Replicating (MVA-BN) (IMVANEX)EMA Same Bavarian Nordic MVA-BN vaccine as JYNNEOS, marketed under a different name in the EU. Smallpox and Mpox (Vaccinia) Vaccine, Live (ACAM2000)FDA | Antivirals Tecovirimat | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Venezuelan equine encephalitis virus (VEEV) | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Rodent, Culex mosquito, [Human, Horse] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Dendritic cells Secondary: Spleen ![]() | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Vesiculovirus, Rhabdoviridae | Host / Reservoir [occasional host] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Alphavirus, Togaviridae | Host / Reservoir [occasional host] Vertebrates, mosquitoes, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Polyomavirus, Polyomaviridae | Host / Reservoir [occasional host] Human | Epidemiology | Incidence / prevalence — | Geography — | Transmission Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Flavivirus, Flaviviridae | Host / Reservoir [occasional host] Birds, Culex mosquito, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Immune system Secondary: Lymphocytes, | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Orthopoxvirus, Poxviridae | Host / Reservoir [occasional host] Monkeys, Mosquito, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate) | Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus Tanapox virus (TANV) + Yaba-like disease virus (YLDV) | Genus, Family Orthopoxvirus, Poxviridae | Host / Reservoir [occasional host] Monkeys, Mosquito, [Human] | Epidemiology — | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Flavivirus, Flaviviridae | Host / Reservoir [occasional host] Monkeys, Aedes mosquito, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] Primary: Immune system *-First viremia* Secondary: Liver | Pathology (fatality rate)
| Vaccine | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Virus | Genus, Family Flavivirus, Flaviviridae | Host / Reservoir [occasional host] Monkeys, Aedes mosquito, [Human] | Epidemiology | Incidence / prevalence — | Geography — | Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tropism: organ [cell type] | Pathology (fatality rate)
| Vaccine NO APPROVED VACCINE | Antivirals — | Genome assembly | Genome (non-segmented) | Proteome | Cell culture — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||